: BIONTECH SAYS DATA INDICATE THAT THE VACCINE IS STILL EFFECTIVE IN PREVENTING COVID-19, ALSO AGAINST OMICRON, IF IT HAS BEEN ADMINISTERED THREE TIMES
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022
Comentarios:
OPTIMISM
Weakness JPY, weakness gold, strength equities
Comentarios:
Exención de responsabilidad
La información y las publicaciones que ofrecemos, no implican ni constituyen un asesoramiento financiero, ni de inversión, trading o cualquier otro tipo de consejo o recomendación emitida o respaldada por TradingView. Puede obtener información adicional en las Condiciones de uso.
: PFIZER INC - DATA INDICATE THAT THIRD DOSE OF BNT162B2 INCREASES NEUTRALIZING ANTIBODY TITERS BY 25-FOLD COMPARED TO TWO DOSES AGAINST OMICRON VARIANT
: PFIZER INC - HAVE HIGH CONFIDENCE THAT IF NEEDED THEY CAN DELIVER AN OMICRON-BASED VACCINE IN MARCH 2022